secwatch / observer
8-K filed August 27, 2025, 7:59 PM ET ticker SONM CIK 0001178697
regulatory confidence high sentiment negative materiality 0.75

DNA X, Inc. (SONM): Nasdaq/NYSE listing notice — Sonim receives Nasdaq deficiency notice for low stockholders' equity of $1.334M

DNA X, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

DNA X, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1), 5550(b)(2), 5550(b)(3)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
stockholders equity
Rules
5550(b)(1), 5550(b)(2), 5550(b)(3)
Exact text from the filing
August 22, 2025, Sonim Technologies, Inc. (the “Company”) received a letter (the “Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company’s stockholders’ equity, as reported in its Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the “Form 10-Q”), did not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1) for the Nasdaq Capital Market, which requires that a listed company’s stockholders’ equity be at least $2.5 million. As reported on its Form 10-Q, the Company’s stockholders’ equity as of June 30, 2025 was $1,334
View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

DNA X, Inc. filing history →

Source: SEC EDGAR
accession 0001641172-25-025693
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.